Circulation. 2002;105:1861-1870
doi: 10.1161/01.CIR.0000012467.61045.87
doi: 10.1161/01.CIR.0000012467.61045.87
(Circulation. 2002;105:1861.)
© 2002 American Heart Association, Inc.
Current Perspective |
Adaptation and Maladaptation of the Heart in Diabetes: Part II
Potential Mechanisms
Department of Internal Medicine, Division of Cardiology, University of Texas-Houston Medical School, Houston, Tex (M.E.Y., H.T.), and Cardiology Section, Penn State University College of Medicine, The Milton S. Hershey Medical Center, Hershey, Pa (P.M.).
Correspondence to Heinrich Taegtmeyer, MD, DPhil, Department of Internal Medicine, Division of Cardiology, University of Texas-Houston Medical School, 6431 Fannin, MSB 1.246, Houston, TX 77030. E-mail Heinrich.Taegtmeyer@uth.tmc.edu
Key Words: diabetes mellitus • heart failure • cardiovascular diseases
 |
Introduction |
|---|
The prevailing concept of the heart’s response to changes in its environment is a complex network of inter-connecting signal transduction cascades.1 In such a scheme, the focus is on communication of various cell surface receptors, heterotrimeric G-proteins, protein kinases, and transcription factors.2–4
Diabetes is a disorder of metabolic dysregulation. At first glance it appears that metabolism and the metabolic consequences of diabetes do not fit into this signal-response coupling scheme. Two questions arise. First, is metabolism simply an "effect" rather than a "cause" of adaptation? Second, is metabolism only a by-product of signal transduction-induced adaptation, allowing equilibrium (and therefore maintenance of function) in the presence of the other adaptational responses?
An alternative is to take a new, less restricted view of metabolism. Beyond its stereotypical function as a provider of ATP, alterations in metabolic flux within the cell create essential signals for the adaptation of the heart to situations such as diabetes. This concept is novel for the heart, but has already been considered in the liver. Like the phosphorylation events occurring in signal transduction cascades, changes in metabolic flux are extremely rapid. For example, translocation of GLUT4 to the cell surface in response to insulin occurs within a second.5 We have previously found that increases or decreases in workload also change metabolic fluxes in seconds.6,7 Therefore, changes in metabolites are rapid enough to allow them to act as signaling molecules.
Many of these acute changes in metabolic flux are brought about by the same signal transduction cascades believed to
This article has been cited by other articles:
 |
|
 |
|
  R. Marfella, C. Di Filippo, M. Portoghese, M. Barbieri, F. Ferraraccio, M. Siniscalchi, F. Cacciapuoti, F. Rossi, M. D'Amico, and G. Paolisso Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome J. Lipid Res., November 1, 2009; 50(11): 2314 - 2323. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Young Anticipating anticipation: pursuing identification of cardiomyocyte circadian clock function J Appl Physiol, October 1, 2009; 107(4): 1339 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Ussher, T. R. Koves, J. S. Jaswal, L. Zhang, O. Ilkayeva, J. R.B. Dyck, D. M. Muoio, and G. D. Lopaschuk Insulin-Stimulated Cardiac Glucose Oxidation Is Increased in High-Fat Diet-Induced Obese Mice Lacking Malonyl CoA Decarboxylase Diabetes, August 1, 2009; 58(8): 1766 - 1775. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Nielsen, S. B. Kristiansen, R. Norregaard, C. L. Andersen, L. Denner, T. T. Nielsen, A. Flyvbjerg, and H. E. Botker Blockage of receptor for advanced glycation end products prevents development of cardiac dysfunction in db/db type 2 diabetic mice Eur J Heart Fail, July 1, 2009; 11(7): 638 - 647. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-G. Niu and R. D. Evans Myocardial metabolism of triacylglycerol-rich lipoproteins in type 2 diabetes J. Physiol., July 1, 2009; 587(13): 3301 - 3315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Gropler Lost in Translation: Modulation of the Metabolic-Functional Relation in the Diabetic Human Heart Circulation, April 21, 2009; 119(15): 2020 - 2022. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Akki and A.-M. L. Seymour Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy Cardiovasc Res, February 15, 2009; 81(3): 610 - 617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Rijzewijk, R. W. van der Meer, J. W.A. Smit, M. Diamant, J. J. Bax, S. Hammer, J. A. Romijn, A. de Roos, and H. J. Lamb Myocardial Steatosis Is an Independent Predictor of Diastolic Dysfunction in Type 2 Diabetes Mellitus. J. Am. Coll. Cardiol., November 25, 2008; 52(22): 1793 - 1799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Von Bibra, M. Diamant, P. G Scheffer, T. Siegmund, and P.-M. Schumm-Draeger Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 310 - 318. [Abstract] [PDF]
|
|
|
|
 |
|
 Y.-G. Niu and R. D. Evans Metabolism of very-low-density lipoprotein and chylomicrons by streptozotocin-induced diabetic rat heart: effects of diabetes and lipoprotein preference Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1106 - E1116. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Wu, E. Y. Zhang, J. Zhang, R. J. Bache, and D. A. Beard Phosphate metabolite concentrations and ATP hydrolysis potential in normal and ischaemic hearts J. Physiol., September 1, 2008; 586(17): 4193 - 4208. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Yamamoto, Y.-F. Dong, K. Kataoka, T. Yamashita, Y. Tokutomi, S. Matsuba, H. Ichijo, H. Ogawa, and S. Kim-Mitsuyama Olmesartan Prevents Cardiovascular Injury and Hepatic Steatosis in Obesity and Diabetes, Accompanied by Apoptosis Signal Regulating Kinase-1 Inhibition Hypertension, September 1, 2008; 52(3): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Harmancey, C. R. Wilson, and H. Taegtmeyer Adaptation and Maladaptation of the Heart in Obesity Hypertension, August 1, 2008; 52(2): 181 - 187. [Full Text] [PDF]
|
|
|
|
|
|
M. S. Bray and M. E. Young Diurnal variations in myocardial metabolism Cardiovasc Res, July 15, 2008; 79(2): 228 - 237. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Soliman, G. P. Craig, P. Nagareddy, V. G. Yuen, G. Lin, U. Kumar, J. H. McNeill, and K. M. MacLeod Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats Cardiovasc Res, July 15, 2008; 79(2): 322 - 330. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. T. Nguyen and D. G. Benditt Atrial Fibrillation Susceptibility in Metabolic Syndrome: Simply the Sum of Its Parts? Circulation, March 11, 2008; 117(10): 1249 - 1251. [Full Text] [PDF]
|
|
|
|
|
|
R. M. Witteles and M. B. Fowler Insulin-Resistant Cardiomyopathy: Clinical Evidence, Mechanisms, and Treatment Options J. Am. Coll. Cardiol., January 15, 2008; 51(2): 93 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Szczepaniak, R. G. Victor, L. Orci, and R. H. Unger Forgotten but Not Gone: The Rediscovery of Fatty Heart, the Most Common Unrecognized Disease in America Circ. Res., October 12, 2007; 101(8): 759 - 767. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Durgan, M. W. S. Moore, N. P. Ha, O. Egbejimi, A. Fields, U. Mbawuike, A. Egbejimi, C. A. Shaw, M. S. Bray, V. Nannegari, et al. Circadian rhythms in myocardial metabolism and contractile function: influence of workload and oleate Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2385 - H2393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. McGavock, I. Lingvay, I. Zib, T. Tillery, N. Salas, R. Unger, B. D. Levine, P. Raskin, R. G. Victor, and L. S. Szczepaniak Cardiac Steatosis in Diabetes Mellitus: A 1H-Magnetic Resonance Spectroscopy Study Circulation, September 4, 2007; 116(10): 1170 - 1175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. D. Lopaschuk, C. D.L. Folmes, and W. C. Stanley Cardiac Energy Metabolism in Obesity Circ. Res., August 17, 2007; 101(4): 335 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. P. Singh, B. Le, V. B. Bhat, K. M. Baker, and R. Kumar High-glucose-induced regulation of intracellular ANG II synthesis and nuclear redistribution in cardiac myocytes Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H939 - H948. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ashrafian, M. P. Frenneaux, and L. H. Opie Metabolic Mechanisms in Heart Failure Circulation, July 24, 2007; 116(4): 434 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lin, G. P. Craig, L. Zhang, V. G. Yuen, M. Allard, J. H. McNeill, and K. M. MacLeod Acute inhibition of Rho-kinase improves cardiac contractile function in streptozotocin-diabetic rats Cardiovasc Res, July 1, 2007; 75(1): 51 - 58. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Wachter, C. Luers, S. Kleta, K. Griebel, C. Herrmann-Lingen, L. Binder, N. Janicke, D. Wetzel, M. M. Kochen, and B. Pieske Impact of diabetes on left ventricular diastolic function in patients with arterial hypertension Eur J Heart Fail, May 1, 2007; 9(5): 469 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Arikawa, R. C.W. Ma, K. Isshiki, I. Luptak, Z. He, Y. Yasuda, Y. Maeno, M. E. Patti, G. C. Weir, R. A. Harris, et al. Effects of Insulin Replacements, Inhibitors of Angiotensin, and PKC{beta}'s Actions to Normalize Cardiac Gene Expression and Fuel Metabolism in Diabetic Rats Diabetes, May 1, 2007; 56(5): 1410 - 1420. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Held, H.C. Gerstein, S. Yusuf, F. Zhao, L. Hilbrich, C. Anderson, P. Sleight, K. Teo, and for the ONTARGET/TRANSCEND Investigators Glucose Levels Predict Hospitalization for Congestive Heart Failure in Patients at High Cardiovascular Risk Circulation, March 20, 2007; 115(11): 1371 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. D.L. Folmes and G. D. Lopaschuk Role of malonyl-CoA in heart disease and the hypothalamic control of obesity Cardiovasc Res, January 15, 2007; 73(2): 278 - 287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Matsushima, S. Kinugawa, T. Ide, H. Matsusaka, N. Inoue, Y. Ohta, T. Yokota, K. Sunagawa, and H. Tsutsui Overexpression of glutathione peroxidase attenuates myocardial remodeling and preserves diastolic function in diabetic heart Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2237 - H2245. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Reyes, M. E. Steinhelper, J. A. Alvarez, D. Escobedo, J. Pearce, J. W. Valvano, B. H. Pollock, C.-L. Wei, A. Kottam, D. Altman, et al. Impact of physiological variables and genetic background on myocardial frequency-resistivity relations in the intact beating murine heart Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1659 - H1669. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. An and B. Rodrigues Role of changes in cardiac metabolism in development of diabetic cardiomyopathy Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1489 - H1506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Durgan, N. A. Trexler, O. Egbejimi, T. A. McElfresh, H. Y. Suk, L. E. Petterson, C. A. Shaw, P. E. Hardin, M. S. Bray, M. P. Chandler, et al. The Circadian Clock within the Cardiomyocyte Is Essential for Responsiveness of the Heart to Fatty Acids J. Biol. Chem., August 25, 2006; 281(34): 24254 - 24269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Lautamaki, R. Borra, P. Iozzo, M. Komu, T. Lehtimaki, M. Salmi, S. Jalkanen, K. E. J. Airaksinen, J. Knuuti, R. Parkkola, et al. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E282 - E290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Durgan, J. K. Smith, M. A. Hotze, O. Egbejimi, K. D. Cuthbert, V. G. Zaha, J. R. B. Dyck, E. D. Abel, and M. E. Young Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2480 - H2497. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. H. McNulty Metabolic responsiveness to insulin in the diabetic heart Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1749 - H1751. [Full Text] [PDF]
|
|
|
|
|
|
N. D. Oakes, P. Thalen, E. Aasum, A. Edgley, T. Larsen, S. M. Furler, B. Ljung, and D. Severson Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E870 - E881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Hafstad, G. H. Solevag, D. L. Severson, T. S. Larsen, and E. Aasum Perfused hearts from Type 2 diabetic (db/db) mice show metabolic responsiveness to insulin Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1763 - H1769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O.-J. How, E. Aasum, D. L. Severson, W.Y. A. Chan, M. F. Essop, and T. S. Larsen Increased Myocardial Oxygen Consumption Reduces Cardiac Efficiency in Diabetic Mice Diabetes, February 1, 2006; 55(2): 466 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Young The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H1 - H16. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Monti, E. Setola, G. Fragasso, R. P. Camisasca, P. Lucotti, E. Galluccio, A. Origgi, A. Margonato, and P. Piatti Metabolic and endothelial effects of trimetazidine on forearm skeletal muscle in patients with type 2 diabetes and ischemic cardiomyopathy Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E54 - E59. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Buchanan, P. K. Mazumder, P. Hu, G. Chakrabarti, M. W. Roberts, U. J. Yun, R. C. Cooksey, S. E. Litwin, and E. D. Abel Reduced Cardiac Efficiency and Altered Substrate Metabolism Precedes the Onset of Hyperglycemia and Contractile Dysfunction in Two Mouse Models of Insulin Resistance and Obesity Endocrinology, December 1, 2005; 146(12): 5341 - 5349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Bartnik, K. Malmberg, and L. Ryden Management of patients with type 2 diabetes after acute coronary syndromes Diabetes and Vascular Disease Research, October 1, 2005; 2(3): 144 - 154. [Abstract] [PDF]
|
|
|
|
|
|
G. Perseghin, P. Fiorina, F. De Cobelli, P. Scifo, A. Esposito, T. Canu, M. Danna, C. Gremizzi, A. Secchi, L. Luzi, et al. Cross-Sectional Assessment of the Effect of Kidney and Kidney-Pancreas Transplantation on Resting Left Ventricular Energy Metabolism in Type 1 Diabetic-Uremic Patients: A Phosphorous-31 Magnetic Resonance Spectroscopy Study J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1085 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Taegtmeyer Glucose for the Heart: Too Much of a Good Thing? J. Am. Coll. Cardiol., July 5, 2005; 46(1): 49 - 50. [Full Text] [PDF]
|
|
|
|
 |
|
 W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Wang, S. G. Lloyd, H. Zeng, A. Bonen, and J. C. Chatham Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2102 - H2110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. S. Thrainsdottir, T. Aspelund, G. Thorgeirsson, V. Gudnason, T. Hardarson, K. Malmberg, G. Sigurdsson, and L. Ryden The Association Between Glucose Abnormalities and Heart Failure in the Population-Based Reykjavik Study Diabetes Care, March 1, 2005; 28(3): 612 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Wisniacki, W Taylor, M Lye, and J P H Wilding Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure Heart, January 1, 2005; 91(1): 32 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Stavinoha, J. W. RaySpellicy, M. L. Hart-Sailors, H. J. Mersmann, M. S. Bray, and M. E. Young Diurnal variations in the responsiveness of cardiac and skeletal muscle to fatty acids Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E878 - E887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Stavinoha, J. W. RaySpellicy, M. F. Essop, C. Graveleau, E. D. Abel, M. L. Hart-Sailors, H. J. Mersmann, M. S. Bray, and M. E. Young Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-{alpha}-regulated gene in cardiac and skeletal muscle Am J Physiol Endocrinol Metab, November 1, 2004; 287(5): E888 - E895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Scheuer Fueling the Hypertrophied Heart Hypertension, November 1, 2004; 44(5): 623 - 624. [Full Text] [PDF]
|
|
|
|
|
|
D. Aguilar, S. D. Solomon, L. Kober, J.-L. Rouleau, H. Skali, J. J.V. McMurray, G. S. Francis, M. Henis, C. M. O'Connor, R. Diaz, et al. Newly Diagnosed and Previously Known Diabetes Mellitus and 1-Year Outcomes of Acute Myocardial Infarction: The Valsartan in Acute Myocardial Infarction (VALIANT) Trial Circulation, September 21, 2004; 110(12): 1572 - 1578. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Mazumder, B. T. O'Neill, M. W. Roberts, J. Buchanan, U. J. Yun, R. C. Cooksey, S. Boudina, and E. D. Abel Impaired Cardiac Efficiency and Increased Fatty Acid Oxidation in Insulin-Resistant ob/ob Mouse Hearts Diabetes, September 1, 2004; 53(9): 2366 - 2374. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. D. Monti, C. Landoni, E. Setola, E. Galluccio, P. Lucotti, E. P. Sandoli, A. Origgi, G. Lucignani, P. Piatti, and F. Fazio Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1225 - H1231. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Magnusson, O. Melander, B. Israelsson, A. Grubb, L. Groop, and S. Jovinge Elevated Plasma Levels of Nt-proBNP in Patients With Type 2 Diabetes Without Overt Cardiovascular Disease Diabetes Care, August 1, 2004; 27(8): 1929 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. Suys, N. Katier, R. P.A. Rooman, D. Matthys, L. Op De Beeck, M. V.L. Du Caju, and D. De Wolf Female Children and Adolescents With Type 1 Diabetes Have More Pronounced Early Echocardiographic Signs of Diabetic Cardiomyopathy Diabetes Care, August 1, 2004; 27(8): 1947 - 1953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. H. Young Diastolic Function and Type 1 Diabetes Diabetes Care, August 1, 2004; 27(8): 2081 - 2083. [Full Text] [PDF]
|
|
|
|
|
|
L. Raimondi, P. De Paoli, E. Mannucci, G. Lonardo, L. Sartiani, G. Banchelli, R. Pirisino, A. Mugelli, and E. Cerbai Restoration of Cardiomyocyte Functional Properties by Angiotensin II Receptor Blockade in Diabetic Rats Diabetes, July 1, 2004; 53(7): 1927 - 1933. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. de Groote, N. Lamblin, F. Mouquet, D. Plichon, E. McFadden, E. Van Belle, and C. Bauters Impact of diabetes mellitus on long-term survival in patients with congestive heart failure Eur. Heart J., April 2, 2004; 25(8): 656 - 662. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. H. Opie Angina Pectoris: The Evolution of Concepts Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S3 - S9. [PDF]
|
|
|
|
|
|
A. N. Carley, L. M. Semeniuk, Y. Shimoni, E. Aasum, T. S. Larsen, J. P. Berger, and D. L. Severson Treatment of type 2 diabetic db/db mice with a novel PPAR{gamma} agonist improves cardiac metabolism but not contractile function Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E449 - E455. [Abstract] [Full Text]
|
|
|
|
|
|
B. F. Johnson, R. W. Nesto, M. A. Pfeifer, W. R. Slater, A. I. Vinik, D. A. Chyun, G. Law, F. J.Th. Wackers, and L. H. Young Cardiac Abnormalities in Diabetic Patients With Neuropathy: Effects of aldose reductase inhibitor administration Diabetes Care, February 1, 2004; 27(2): 448 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Taegtmeyer and P. Razeghi Heart disease in diabetes--resist the beginnings J. Am. Coll. Cardiol., January 21, 2004; 43(2): 315 - 315. [Full Text] [PDF]
|
|
|
|
|
|
D. S.H. Bell Diabetic Cardiomyopathy Diabetes Care, October 1, 2003; 26(10): 2949 - 2951. [Full Text] [PDF]
|
|
|
|
|
|
T. Tanaka, T. Kono, F. Terasaki, T. Kintaka, K. Sohmiya, T. Mishima, and Y. Kitaura Gene-environment interactions in wet beriberi: effects of thiamine depletion in CD36-defect rats Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1546 - H1553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. V. Turko and F. Murad Quantitative Protein Profiling in Heart Mitochondria from Diabetic Rats J. Biol. Chem., September 12, 2003; 278(37): 35844 - 35849. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Borghi, S. Bacchelli, D. D. Esposti, and E. Ambrosioni Effects of the Early ACE Inhibition in Diabetic Nonthrombolyzed Patients With Anterior Acute Myocardial Infarction Diabetes Care, June 1, 2003; 26(6): 1862 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Candido, J. M. Forbes, M. C. Thomas, V. Thallas, R. G. Dean, W. C. Burns, C. Tikellis, R. H. Ritchie, S. M. Twigg, M. E. Cooper, et al. A Breaker of Advanced Glycation End Products Attenuates Diabetes-Induced Myocardial Structural Changes Circ. Res., April 18, 2003; 92(7): 785 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Rutter, H. Parise, E. J. Benjamin, D. Levy, M. G. Larson, J. B. Meigs, R. W. Nesto, P. W.F. Wilson, and R. S. Vasan Impact of Glucose Intolerance and Insulin Resistance on Cardiac Structure and Function: Sex-Related Differences in the Framingham Heart Study Circulation, January 28, 2003; 107(3): 448 - 454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bartnik, K. Malmberg, and L. Ryden Diabetes and the heart: compromised myocardial function -- a common challenge Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B33 - B41. [Abstract] [PDF]
|
|
|
|
|
|
Z. He, C. Rask-Madsen, and G.L. King Mechanisms of cardiovascular complications in diabetes and potential new pharmacological therapies Eur. Heart J. Suppl., January 1, 2003; 5(suppl_B): B51 - B57. [Abstract] [PDF]
|
|